News

BSR has published an updated guideline on the safe use of csDMARDs, introducing new evidence, paediatric guidance, and risk-adaptive monitoring across the full life course.

Engineered herpes virus targets glioblastoma cells, destroying tumours while activating immune defences in preclinical brain cancer models.

New test shows high sensitivity for tuberculosis, providing a faster, near-point-of-care option for early detection and prevention.

Early-stage primary biliary cholangitis shows distinct blood lipid changes tied to inflammation and fibrosis, offering clues to disease activity and potential new biomarkers.

A large retrospective study shows JAK2 gene fusion occurs in both aggressive and indolent cutaneous T-cell lymphomas, offering new insight into diagnosis and targeted treatment.

An automated MRI decision aid (ProAI) improves detection of clinically significant prostate cancer, boosting accuracy and cutting radiology workload by 32%.

Over half of patients with severe asthma discontinued oral corticosteroids while maintaining disease control, major study finds.

Phase 1 trial shows single-fraction stereotactic breast irradiation is safe and effective